Marta Barrachina: 'I am confident that there will be advances in Alzheimer’s in the short term'

by GENESIS Biomed

Despite the Covid-19 pandemic, 2020 has been a great year for ADmit Therapeutics, a spin-off from Bellvitge Biomedical Research Institute (IDIBELL, in Barcelona) born at the end of 2017 and leaded by ...

Read more

ADmit Therapeutics recibe 3,3 millones de euros de la Comisión Europea para llevar su prueba de diagnóstico precoz del Alzheimer al mercado

by ADmit Therapeutics

La spin-of del IDIBELL, creada en 2017 y con sede en L'Hospitalet de Llobregat, es una de las 36 empresas seleccionadas de entre las 1.406 solicitudes recibidas en la convocatoria EIC Accelerator del ...

Read more

Covid-19: first-hand experiences from entrepreneurs

by GENESIS Biomed

The SARS-CoV-2 pandemic that is hitting many countries has clearly affected the medical start-up and spin-off ecosystem. After talking to some of the companies we support we have seen that it has not ...

Read more

ADmit Therapeutics, backed by Ship2B, GENESIS Biomed and BStartup, obtains the support of the Alzheimer’s Drug Discovery Foundation

by GENESIS Biomed

ADmit Therapeu​tics has received an investment of 497.652$ from the ADDF Diagnostics Accelerator for the development of its early Alzheimer’s disease diagnostic test in blood samples. The Diagnost...

Read more

ADmit Therapeutics obtains the support of the Alzheimer’s Drug Discovery Foundation (ADDF) to develop its early Alzheimer’s diagnostic test

by Hospital Universitari de Bellvitge

​ADmit Therapeutics has received an investment of 497.652$ from the ADDF Diagnostics Accelerator for the development of its early Alzheimer’s disease diagnostic test in blood samples. The Diagnost...

Read more
Subscribe to Directory
Write an Article

Recent News

Tuneable reverse photochromes in the sol...

A new technique allows the design of solid materia...

La Unidad de Chequeos de la Clínica sup...

El estudio realizado sobre una muestra significati...

Highlight

Interview with Dámaso Molero, general m...

by 3P Biopharmaceuticals

Dámaso Molero: “There are great opportunities in Latin America for ...

La impronta inmunológica condiciona la ...

by Hospital Universitari de Bellvitge

Un estudio del Hospital de Bellvitge, el IDIBELL y la Icahn School of ...

Photos Stream